The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FDG PET-CT imaging in assessing interim response to neoadjuvant cisplatin-based chemotherapy (NAC) in muscle invasive bladder cancer (MIBC): A prospective study.
 
Srikala S. Sridhar
Consulting or Advisory Role - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Immunomedics (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst)
Research Funding - Bayer (Inst); Janssen (Inst); Pfizer (Inst)
 
Nicholas Power
No Relationships to Disclose
 
Rodney H. Breau
No Relationships to Disclose
 
Susanna Y. Cheng
Honoraria - AstraZeneca; Merck
Consulting or Advisory Role - AstraZeneca/MedImmune; Merck
Speakers' Bureau - Pfizer/EMD Serono
 
Gregory Russell Pond
Employment - Roche Canada (I)
Stock and Other Ownership Interests - Roche Canada (I)
Honoraria - AstraZeneca; AstraZeneca
Consulting or Advisory Role - Merck; Profound Medical; Takeda
 
Peter W. M. Chung
Honoraria - Abbvie; AstraZeneca; Boston Scientific
Consulting or Advisory Role - Tersera; Tolmar; Verity Pharmaceuticals
Research Funding - Abbvie
 
Ur Metser
Employment - POINT Biopharma
Consulting or Advisory Role - POINT Biopharma
 
Mark Norman Levine
No Relationships to Disclose
 
Som D. Mukherjee
Consulting or Advisory Role - EMD Serono/Merck
Travel, Accommodations, Expenses - Amgen